Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients in Europe die annually from the disease² If approved by the European Commission, ORSERDU would be the first…

SAN DIEGO, 21 de julho de 2023 /PRNewswire/– A Invivoscribe tem o prazer de anunciar que o Exame de Mutação LeukoStrat® CDx FLT3 foi aprovado pela Agência de Administração de Alimentos e Medicamentos dos EUA (FDA) para ajudar na seleção de pacientes recém-diagnosticados com Leucemia…

“Howl to the Hill” event shines a light on the USDA’s shameful pattern of inaction, with advocates calling on Congress to pass Goldie’s Act WASHINGTON, July 21, 2023 /PRNewswire/ — Yesterday, the ASPCA® (The American Society for the Prevention of Cruelty to Animals®) hosted “Howl to the…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.